Study Stopped
Study terminated due to lack of funding.
Stem Cell Study for Subjects With Congestive Heart Failure
Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40%
Sponsor study identifier
Secondary identifiers
OTHER · Sponsor protocol number
interventional
4
1 country
1
Study Start
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2011
Actual (reported)Study Completion
Not reported
Date not reportedThe purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 7, 2008
Actual (reported)February 21, 2008
Actual (reported)March 2008
Date type not reportedThis date has not been verified as actual or estimated.
January 2011
Actual (reported)Safety of intramyocardial administration of CD34-positive cells
6 months
Effects of intramyocardial injections of autologous CD34-positive cells on clinical outcomes.
6 months
Comparison between a low dose and high dose of autologous (one's own) CD34-positive cells (stem cells) delivered via injections into the heart muscle.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Northwestern University
Chicago, Illinois, 60611, United States
Douglas W. Losordo, M.D.
Northwestern University
4 participants (actual enrollment reported by the registry).
First Submitted
February 7, 2008
First Posted
February 21, 2008
Study Start
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure
Contact the study team to confirm eligibility.
Primary Completion
January 2011
Actual (reported)Last Updated
March 31, 2015
Record last verified: 2011-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: